Novatek Pharmaceuticals, Inc. — Form C (Regulation Crowdfunding)
Novatek Pharmaceuticals, Inc. of Pearland, TX filed a Form C (Regulation Crowdfunding) with the SEC on 2022-12-21. Target raise $50K, up to $5.0M. Offered through Deal Maker.
Offering
- Filed: 2022-12-21
- Form: C
- Accession: 0001952985-22-000002
- Target amount: $50K
- Maximum amount: $5.0M
- Security type: Common Stock
- Securities offered: 25,000
- Price: $2.0000
- Deadline: 2023-12-14
- Funding portal / intermediary: Deal Maker
- Intermediary file number: 008-70756
- Intermediary CRD: 315324
Issuer
- CIK: 0001952985
- Website: www.novatekpharmceuticals.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2020-04-30
- Address: 3569 Business Center Drive, Pearland, TX, 77584
- Employees: 5
Financials (as filed)
- Total assets (most recent): $17K
- Cash (most recent): $17K
- Net income (most recent): $3.4M
- Net income (prior): $1.1M
- Short-term debt: $2.2M
- Long-term debt: $2.3M
People (2)
| Name | Role | Location |
|---|
| Alex Saliba | CFO | Pearland, TX |
| Mohamed Kaseb | CEO | Pearland, TX |
More